Bevacizumab in combination with oxaliplatin and either fluorouracil plus folinic acid or capecitabine for the treatment of metastatic colorectal cancer
Technology appraisal guidance
Reference number: TA212
Published:
Tools and resources
Tools and resources to help you put the guidance into practice.